- Headquarters
- Redwood City
- Employees
- 11–50
- Founded
- 2010
- Business Model
- B2B
- Website
- atreca.com
- Total Funding
- $125.0M
- Last Round
- $125.0M Series CSep 2018
- Rounds
- 1
About
Atreca is a clinical-stage biopharmaceutical company developing novel cancer immunotherapeutics by leveraging deep insights into the human immune response. Its proprietary Immune Repertoire Capture (IRC) technology identifies antibodies generated by the immune systems of cancer patients to discover novel therapeutic targets. Founded in 2010 and based in Redwood City, California, Atreca underwent significant workforce reductions in 2022-2023 while pivoting its pipeline toward antibody-drug conjugates.
Summary
Atreca is a Biotech company based in Redwood City, United States, founded in 2010. It has raised $125.0M in total across 1 round, most recently a $125.0M Series C round in Sep 2018.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2018
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform